The yield has risen 73.6 basis points over the past seven weeks, according to Dow Jones Market Data. On Friday, traders were ...

Lower Manhattan-based Metsera is one of the latest drug startups to throw its hat into the ring with the pharma giants ...

GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

Four out of five men and women in the United States will be overweight or obese by 2050 if current trends hold, a new study ...

Rasheeda Bush and her son, Brian Bush, have together lost over 200 pounds using diabetes and weight loss medications.

Sharon Osbourne sparked surgery concern once again this week as she stepped out in LA on Wednesday with a noticeably more ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

The company's revenue jumped 77% in Q3 to reach $401.6 million in Q3 2024, alongside a net income of $75.6 million. It now ...

Researchers said the analysis lays bare a ‘decades-long-failure’ to tackle the overweight and obesity epidemic ...

A new study supports the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to ...